Gainers
- Helius Medical Tech HSDT shares moved upwards by 65.1% to $1.24 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.6 million.
- Dogwood Therapeutics DWTX stock moved upwards by 32.62% to $2.48. The market value of their outstanding shares is at $3.3 million.
- GlucoTrack GCTK stock increased by 32.5% to $0.11. The company's market cap stands at $1.8 million.
- Replimune Group REPL stock increased by 22.48% to $12.42. The company's market cap stands at $955.7 million.
- Tempus AI TEM stock increased by 22.19% to $42.95. The company's market cap stands at $6.7 billion.
- Evolus EOLS shares increased by 21.78% to $12.8. The company's market cap stands at $810.5 million.
Losers
- Scorpius Holdings SCPX stock fell 23.0% to $0.28 during Tuesday's pre-market session. The company's market cap stands at $1.3 million.
- Hepion Pharmaceuticals HEPA shares fell 14.65% to $0.4. The company's market cap stands at $2.7 million.
- Biomerica BMRA stock declined by 13.21% to $0.56. The company's market cap stands at $10.1 million.
- Lantern Pharma LTRN shares decreased by 11.93% to $3.25. The company's market cap stands at $35.0 million.
- Baird Medical Investment BDMD shares decreased by 11.87% to $7.8. The company's market cap stands at $283.6 million.
- AEON Biopharma AEON shares fell 9.23% to $0.14. The market value of their outstanding shares is at $11.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BDMDBaird Medical Investment Holdings Ltd
$7.03-20.6%
BMRABiomerica Inc
$0.5928-7.38%
DWTXDogwood Therapeutics Inc
$3.0764.2%
EOLSEvolus Inc
$13.4728.2%
GCTKGlucoTrack Inc
$0.121843.5%
HEPAHepion Pharmaceuticals Inc
$0.3334-28.9%
HSDTHelius Medical Technologies Inc
$0.962428.1%
LTRNLantern Pharma Inc
$4.049.62%
REPLReplimune Group Inc
$11.9117.5%
SCPXScorpius Holdings Inc
$0.3000-18.9%
TEMTempus AI Inc
$47.5035.1%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in